Bausch Health declines on Q4 profit miss
Source: SeekingAlpha
2026-02-18 17:19:23 ET
More on Bausch Health Companies
- Bausch Health: RED-C Failure Leaves Blockbuster Xifaxan Without A Successor
- Bausch Health Companies Inc. (BHC) Presents at 44th Annual J.P. Morgan Healthcare Conference
- Bausch Health Companies Inc. (BHC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Bausch Health Companies Q4 2025 Earnings Preview
- Bausch Health falls on phase 3 failure of liver disease complications drug
Read the full article on Seeking Alpha
For further details see:
Bausch Health declines on Q4 profit miss
Bausch Health Companies Inc.
NASDAQ: BHC
BHC Trading
-0.37% G/L:
$5.365 Last:
741,327 Volume:
$5.36 Open:
BHC Latest News
February 23, 2026 08:00:00 am
Bausch Health's Aesthetics Business, Solta Medical, Announces the Launch of Clear + Brilliant® Touch Laser in Canada
February 19, 2026 08:00:00 am
Bausch Health's OraPharma Celebrates 25 Years of ARESTIN® (minocycline HCl) Microspheres
BHC Stock Data
$2,310,173,034
238,316,487
N/A
76
N/A
Pharmaceuticals
Healthcare
CA
Laval
